MedPath

Probiotics to infants with atopic dermatitis;an investigation of the effect on eczema, immune system and intestinal microflora, inflammation and permeability. DK-titelProbiotiske bakterier til børn med atopisk dermatitis;undersøgelse af effekten på eksem, immunstatus, intestinal mikroflorasamt tarmens inflammation og permeabilitet

Phase 1
Active, not recruiting
Conditions
Infants participating in the clinical trial are suffering from atopic dermatitis
Registration Number
EUCTR2005-003140-56-DK
Lead Sponsor
Department of Human Nutrition, The Royal Veterinary and Agricultural University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Infants at the age of 5 months to 2 years with atopic dermatis, but otherwise
healthy

2. Infants should fulfil the criteria of atopic dermatitis
a. iching eczema within the past 6 weeks or chronic recurrent iching eczema
b. characteristic symmetrical body location of the eczema depending on age
c. clinical symptoms of atopic dermatitis on one or more of the following places:
face/neck; trunk; flexor aspects of arms or legs; extensor aspects of arms or
legs
d. hereditary disposition

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Infants suffering from chronic diseases other than atopic dermatits

2. Infants recieving medication from other diseases than atopic dermatitis

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.